Our Story

KBP Biosciences is a global, clinical stage biopharmaceutical company focused on the development of an
innovative pipeline of new chemical entities with known mechanisms of action targeting underserved
patient populationsin organ protection and infectious diseases.

KBP utilizes an integrated discovery and development platform that enables the Company
to efficiently bring new therapies from bench to patients around the world.

Our lead product candidate, KBP-5074, is a third-generation non-steroidal mineralocorticoid receptor
antagonist (MRA) with a potentially best-in-class safety and efficacy profile. It is in clinical development for
the treatment of uncontrolled hypertension and cardiorenal disease in stage 3b/4 Chronic
Kidney Disease (CKD) patients who have high risk of hyperkalemia.

Global Footprint

Our Leadership

  • Senior Management
  • |
  • Scientific Advisors
Bing Li, Ph.D., M.B.A.
Interim Chief Executive Officer
Fred Yang, Ph.D.
Chief Development Officer
Julia Yang, M.D., M.B.A.
Chief Operating Officer
James McCabe, M.D.
Chief Medical Officer
Russ Belden
Interim Chief Commercial Officer
Vincent J. Benn, Ph.D., M.B.A.
Senior Vice President, Regulatory & Medical Affairs
Pengfei Guo (Murphy), Ph.D.
Senior Vice President of CMC
Xiaojuan Tan (Judy), PMP
SVP of PM and R&D Coordination, KBP China President
Kimberly Miller, MSN, CRNP, MBA
Senior Vice President, Clinical Operations
Yiran Peng (Carl), M.B.A
Senior Vice President, Corporate Development
Xuan He (Samantha)
General Counsel
Jay (Xu-Jie) Zhang, Ph.D.
Vice President, Biology
Yuanju Zhu (Julie), Patent Attorney
Vice President, Patent and Development Affairs
Susan Song, CPA
Vice President, Finance
Richard Alexander McGregor, Ph.D.
Vice President, Business Development

Our Impact

At KBP Biosciences we are dedicated to push the boundaries of science to transform the lives patients around the world.
We are dedicated to delivering value to our communities, our employees, and the environment.

We are responsible for our actions on people and the planet. We are also mindful of our social responsibilities,
and committed to high standards of governance.